Restrictive cardiomyopathy (RCM) has a poor prognosis and limited treatment options apart from heart transplantation (HTx). We report on the first-in-human interventional atrial flow regulator (AFR) implantations in 3 children with RCM, leading to marked clinical and hemodynamic improvement. We propose the AFR as bridge to HTx or destination therapy in RCM. ().
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334142 | PMC |
| http://dx.doi.org/10.1016/j.jaccas.2022.05.010 | DOI Listing |
Publication Analysis
Top Keywords
atrial flow
8
flow regulator
8
regulator postcapillary
4
postcapillary pulmonary
4
pulmonary hypertension
4
hypertension first-in-human
4
first-in-human transcatheter
4
transcatheter afr
4
afr device
4
device implantations
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!